Eyebright Medical Technology (Beijing) Co., Ltd. (SHA:688050)

China · Delayed Price · Currency is CNY

44.74

-0.26 (-0.58%)

Oct 27, 2026, 3:00 PM CST

Market Cap	8.65B -36.5%
Revenue (ttm)	1.63B +7.8%
Net Income	237.46M -39.7%
EPS	1.23 -40.7%
Shares Out	193.44M
PE Ratio	36.45
Forward PE	23.59
Dividend	0.32 (0.72%)
Ex-Dividend Date	Jun 22, 2026

Volume	5,350,145
Open	45.26
Previous Close	45.00
Day's Range	44.69 - 46.39
52-Week Range	35.23 - 71.34
Beta	0.22
Analysts	Buy
Price Target	52.00 (+16.23%)
Earnings Date	Oct 28, 2026

About SHA:688050

Eyebright Medical Technology (Beijing) Co., Ltd. engages in development, production, and commercialization of ophthalmic medical devices in China and internationally. The company provides intraocular lens, trimmers, capsular tension ring, defocus lense, orthokeratology, and contact lenses in the areas of surgical treatment, myopia management, and consumer vision care. It also offers solutions for ophthalmic surgery, refractive error correction, and optometry consumption. The company was founded in 2010 and is headquartered in Beijing, China. [Read more]

Industry Medical Instruments & Supplies

Sector Healthcare

Founded 2010

Employees 2,657

Stock Exchange Shanghai Stock Exchange

Ticker Symbol 688050

Full Company Profile

Financial Performance

In 2025, SHA:688050's revenue was 1.48 billion, an increase of 5.15% compared to the previous year's 1.41 billion. Earnings were 268.17 million, a decrease of -30.96%.

Financial Statements

Analyst Summary

According to 7 analysts, the average rating for 688050 stock is "Buy." The 12-month stock price target is ¥52.00, which is an increase of 16.23% from the latest price.

Price Target

¥52.00

(16.23% upside)

Analyst Consensus: Buy

Stock Forecasts